Uncategorized

John Santilli quoted in Modern Medicine: FDA warns of rare brain infection with MS drug Tecfidera

Posted on by John Santilli

New oral therapies Biogen Idec’s dimethyl fumarate is one of the new market entrants driving the shift to oral therapy growth in MS treatment, according to John Santilli of Access Market Intelligence, which provides business information to the pharmaceutical and healthcare industries. “Although this is Tecfidera’s first incident tied to PML use in more than 100,000 […]

Continue reading →
Uncategorized

John Santilli quoted in Modern Medicine: FDA approves Cyramza in combination with paclitaxel for advanced gastric cancer after prior chemotherapy

Posted on by John Santilli

“Cyramza, approved earlier this year for stomach cancer, is a key product in Lilly’s oncology portfolio,” said John Santilli, of Access Market Intelligence, which provides market intelligence to the pharmaceutical and healthcare industries. “With the colorectal cancer market becoming increasingly crowded, Lilly will need to review the pricing strategy for Cyramza to make sure the drug remains competitive […]

Continue reading →
Market Intelligence

2015 Pharmaceutical Market Trend Vol. II

Posted on by John Santilli

Raising the Bar on performance So as to force companies to get lean, activist investors employ the use of shareholder arbitrage. There is increasing selection in licensing and partnering opportunities, and a reduced margin for error. Market-authorization for one-time results in periodic reevaluation throughout the life cycle of the product. There is relentlessness in the […]

Continue reading →
Market Intelligence

2015 Pharmaceutical Market Trend Vol. I

Posted on by aprilgregory

While the Pharmaceutical Industry has been experiencing many shifts and changes, it is still a 21st Century Growth Industry based on the stats, facts and trends put out by Pharm Exec.More growth expected… Basic science of genomics and biology are leading to a discovery of treatments which are advanced by using the body’s own immune […]

Continue reading →
Dr. Randy Vogenberg

The Changing Roles of P&T Committees: A Look Back at the Last Decade and a Look Forward to 2020

Posted on by Dr. Randy

Originally published at Pharmacy & Therapeutics – November 2014   http://www.nxtbook.com/nxtbooks/medimedia/pt_201411/src/forms/PT_November_2014_iframe_live.html#/38 Market and regulatory changes in the last 10 years, as well as the Affordable Care Act, have resulted in significant modifications to health care delivery models.  Traditionally, P&T committees limited the impact of their decisions to the populations associated with their hospital or health plan; […]

Continue reading →
Market Intelligence

The Reason Silicon Valley Hasn’t Built a Good Health App

Posted on by Greg Judd

Greg Judd’s Insight: Too obvious, and too seldom said. The Silicon Valley whiz kids’ swipes at health care solutions are as insipid as, well, 99 of 100 mobile games they produce in such profusion.  And yet so much money is heaved at them; how could they possibly be on the wrong track? Article location: http://m.theatlantic.com/technology/archive/2012/03/the-reason-silicon-valley-hasnt-built-a-good-health-app/254229/ […]

Continue reading →
Market Intelligence

Choosing a Health Plan Is Hard, Even for a Health Economist

Posted on by Greg Judd

Greg Judd’s Insight: Frakt is frequently an “I’m soooo smarter than you” kind of writer, but this is an almost charmingly modest first-person account of the difficulty with health coverage “markets”. I have to admit that I’m a bit surprised he didn’t boil his process down to some version of “so I realized I needed […]

Continue reading →
Market Intelligence

Budget Time: Remember to include us in your 2015 budget

Posted on by John Santilli

It’s that time of year again – budget time! As the days get shorter and the temperatures cooler, it’s time to remember the important tools that help keep business in the black: marketing your hot new products and budgets. To make the most of these new products and services, you’ll need to stay on top of […]

Continue reading →